Erratum for Gebo et al., "Early Antibody Treatment, Inflammation, and Risk of Post-COVID Conditions"
Document Type
Article
Publication Date
1-16-2024
Recommended Citation
Gebo KA, Heath SL, Fukuta Y, Zhu X, Baksh S, Abraham AG, Habtehyimer F, Shade D, Ruff J, Ram M, Laeyendecker O, Fernandez RE, Patel EU, Baker OR, Shoham S, Cachay ER, Currier JS, Gerber JM, Meisenberg B, Forthal DN, Hammitt LL, Huaman MA, Levine A, Mosnaim GS, Patel B, Paxton JH, Raval JS, Sutcliffe CG, Anjan S, Gniadek T, Kassaye S, Blair JE, Lane K, McBee NA, Gawad AL, Das P, Klein SL, Pekosz A, Bloch EM, Hanley D, Casadevall A, Tobian AAR, Sullivan DJ; CSSC-004 Consortium. Erratum for Gebo et al., "Early antibody treatment, inflammation, and risk of post-COVID conditions". mBio. 2024 Jan 16;15(1):e0297923. doi: 10.1128/mbio.02979-23. Epub 2023 Dec 14. Erratum for: mBio. 2023 Oct 31;14(5):e0061823. doi: 10.1128/mbio.00618-23. PMID: 38095433; PMCID: PMC10790766.